Post-marketing surveillance: Long term efficacy and safety of Valbenazine in patients with tardive dyskinesia
Not Applicable
Recruiting
- Conditions
- Tardive Dyskinesia
- Registration Number
- JPRN-UMIN000049606
- Lead Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Not provided
Exclusion Criteria
-Patients with a history of hypersensitivity to any in-gredients of this drug -Patients with long QT syndrome congenital or a history of Torsades de pointes [excessive QT interval prolongation, ventricular tachycardia (including Torsades de pointes) may occur.]
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method